Sarepta Therapeutics, Inc.
US ˙ NasdaqGS ˙ US8036071004

SecuritySRPT / Sarepta Therapeutics, Inc.
InstitutionGhost Tree Capital, LLC
Latest Disclosed Ownership120,000 shares
Latest Disclosed Value $ 14,986,800
Ghost Tree Capital, LLC ownership in SRPT / Sarepta Therapeutics, Inc.

On November 14, 2024 - Ghost Tree Capital, LLC filed a 13F-HR form disclosing ownership of 120,000 shares of Sarepta Therapeutics, Inc. (US:SRPT) valued at $14,986,800 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 14, 2024 disclosing 55,000 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of 118.18% during the quarter. The current value of the position is $1,948,800 USD.

Ghost Tree Capital, LLC has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 120,000 65,000 118.18 14,987 72.45 4.5271
2024-08-14 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 55,000 -70,000 -56.00 8,690 -46.30 2.7212
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 125,000 25,000 25.00 16,182 67.81 4.4790
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 100,000 60,000 150.00 9,643 98.91 3.1527
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS COM 803607100 40,000 -45,000 -52.94 4,849 -50.20 1.5947
2023-08-14 2023-06-30 13F SAREPTA THERAPEUTICS COM 803607100 85,000 25,000 41.67 9,734 17.70 3.2135
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM 803607100 60,000 5,000 9.09 8,270 16.04 2.4444
2023-02-14 2022-12-31 13F SAREPTA THERAPEUTICS COM 803607100 55,000 -55,000 -50.00 7,127 -41.38 3.0429
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM 803607100 110,000 -20,000 -15.38 12,159 24.77 3.4129
2022-08-15 2022-06-30 13F SAREPTA THERAPEUTICS COM 803607100 130,000 80,000 160.00 9,745 149.49 5.0758
2022-05-16 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 50,000 -50,000 -50.00 3,906 -56.62 0.8477
2022-02-16 2021-12-31 13F SAREPTA THERAPEUTICS COM 803607100 100,000 100,000 9,005 3.2271
2021-08-10 2021-03-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 0 -40,000 -100.00 0 -100.00
2021-02-18 2020-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 40,000 -25,000 -38.46 6,820 -25.28 1.5197
2021-02-16 2020-12-31 13F SAREPTA THERAPEUTICS COM 803607100 40,000 -25,000 6,820 1,483,389.0873
2020-11-16 2020-09-30 13F SAREPTA THERAPEUTICS COM 803607100 65,000 65,000 9,128 2.6382
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -65,000 -100.00 0 -100.00
2020-04-09 2019-12-31 13F/A-2 SAREPTA THERAPEUTICS COM 803607100 65,000 -155,000 -70.45 8,388 -49.38 1.5974
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM 803607100 65,000 -155,000 8,388 1,586,776.1091
2020-04-09 2019-09-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 220,000 -70,000 -24.14 16,570 -62.40 4.2216
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 220,000 -70,000 16,570 4,209,376.4686
2020-04-09 2019-06-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 290,000 290,000 44,066 9.1398
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 290,000 290,000 44,066 9,228,752.2566
2020-04-09 2019-03-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 0 -70,000 -100.00 0 -100.00
2020-04-09 2018-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 70,000 -140,000 -66.67 7,639 -77.48 2.7723
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS COM 803607100 70,000 -140,000 7,639 2,679,542.3135
2020-04-09 2018-09-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 210,000 35,000 20.00 33,917 46.62 7.2093
2018-11-14 2018-09-30 13F SAREPTA THERAPEUTICS COM 803607100 210,000 35,000 33,917 7,224,929.9171
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM 803607100 175,000 -60,000 -25.53 23,132 32.86 6.8077
2018-05-15 2018-03-31 13F SAREPTA THERAPEUTICS COM 803607100 235,000 235,000 17,411 3.5224
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -100,000 -100.00 0 -100.00
2017-11-14 2017-09-30 13F SAREPTA THERAPEUTICS COM 803607100 100,000 100,000 4,536 0.9633
2017-02-14 2016-12-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -150,000 -100.00 0 -100.00
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS COM 803607100 150,000 -50,000 -25.00 9,212 141.53 1.4940
2016-08-12 2016-06-30 13F SAREPTA THERAPEUTICS COM 803607100 200,000 100,000 100.00 3,814 -1.14 1.1014
2016-02-17 2015-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 100,000 90,000 900.00 3,858 1,101.87 1.5797
2016-02-16 2015-12-31 13F SAREPTA THERAPEUTICS COM 803607100 100,000 3,858
2015-11-16 2015-09-30 13F SAREPTA THERAPEUTICS COM 803607100 10,000 10,000 321 0.1445
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICS COM Call 150,000 18,183 n/a n/a n/a
2023-08-14 2023-06-30 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM Call 125,000 17,229 n/a n/a n/a
2017-05-15 2017-03-31 13F SAREPTA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F SAREPTA THERAPEUTICS COM Call 200,000 -42.86 5,486 -74.48 n/a n/a n/a
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS COM Call 350,000 250.00 21,494 1,027.11 n/a n/a n/a
2016-08-12 2016-06-30 13F SAREPTA THERAPEUTICS COM Call 100,000 1,907 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-04-09 2019-12-31 13F/A SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-04-09 2019-09-30 13F/A SAREPTA THERAPEUTICS COM Put 200,000 15,064 n/a n/a n/a
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM Put 200,000 13,000 n/a n/a n/a
2017-02-14 2016-12-31 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F SAREPTA THERAPEUTICS COM Put 400,000 33.33 24,564 329.37 n/a n/a n/a
2016-08-12 2016-06-30 13F SAREPTA THERAPEUTICS COM Put 300,000 5,721 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.